Home » Biosimulation Market

Biosimulation Market By Software Type (PK/PD Modeling And Simulation, Molecular Modeling And Simulation, PBPK Modeling And Simulation, Toxicity Prediction, Trial Design), By Application (Drug Development, Drug Discovery) – Growth, Future Prospects, Competitive Analysis And Forecast 2017 – 2025

Price: $4999

Published: | Report ID: 1686 | Report Format : PDF

The report titled “Global Biosimulation Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall biosimulation market along with the market size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of biosimulation market segments based on software type, application, and different geographies further segmented by countries. Biosimulation techniques are the newest additions to the drug development industry, which are based on the simulation of biological processes via computer programs.

This technique is widely used to predict the path of drug development and has proven beneficial in reducing patient numbers, time, and cost incurred in the entire drug development process, thus proving beneficial for the pharmaceutical industry’s overall growth. Owing to the aforementioned benefits and an increase in awareness, demand, and adoption of biosimulation, this market is presumed to have increased growth in the forecasted period of 2017–2025.

For the purpose of this study, the global biosimulation market is segmented as follows:

By Software Type

  • PK/PD Modeling and Simulation Software
  • Molecular Modeling and Simulation Software
  • PBPK Modeling and Simulation Software
  • Toxicity Prediction Software
  • Trial Design Software
  • Other Software’s

By Application

  • Drug development
  • Preclinical testing
  • Clinical trials
  • Drug discovery
  • Lead Analysis (Identification and Optimization)
  • Target Analysis (Identification and Optimization)
  • Others

Market estimates and forecasts for these segments are provided in US$ Mn, along with the respective compounded annual growth rates (CAGRs) for the period 2017-2025, with 2016 as the base year.

The geographical segmentation of the global biosimulation market comprised regions such as North America, Europe, Asia-Pacific, Latin America & the Middle East, and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. The market size and forecast for these segments during 2015–2025 and their CAGRs for the period 2017–2025 are provided in this report.

The biosimulation market is observed as the most diversified and competitive market, comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Certara USA, Inc., Simulation Plus, Inc., Dassault Systems SA, Schrodinger, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group, Inc., Physiomics PLC, Entelos, Inc., Rhenovia Pharma Ltd., Genedata AG, Evidera, Inc., In Silico Biosciences, Inc., Oxford Drug Design, Insilico Biotechnology AG, Leadinvent Technologies Pvt. Ltd., and Leadscope, Inc.

Based on the type of software, the global biosimulation market is segmented as follows:

  • PK/PD Modeling and Simulation
  • Molecular Modeling and Simulation
  • PBPK modeling and simulation
  • Toxicity Prediction
  • Trial Design
  • Others.

Within this segment, there is a highly consolidated market share, as each and every piece of software would be used during the course of drug development. Each modeling and simulation software is required to predict each stage of drug development. These software programs would determine the course of a clinical trial and assess its success rate. Because of its widely used applications, such as dosage design prior to a clinical trial, pharmacokinetic profiling of a drug, or the success rate of drug administration on treatment outcomes, PK/PD modeling and simulation software has a marginally higher market share than molecular modeling and simulation software.

The global biosimulation market is divided into the following segments based on application:

Drug development

  • Preclinical testing
  • Clinical trials

Drug discovery

  • Lead Analysis (Identification and Optimization)
  • Target Analysis (Identification and Optimization)
  • Others

The drug development segment encapsulates a larger share of the biosimulation market. This dominance is attributed to the increase in the need for a reduction in adverse effects associated with the current drugs available for treatment, which is propelling the demand for in silico systems to aid in the development of improved molecules. The increased demand is also due to the significant increase in success rates of computer-based modeling in drug development.

The drug discovery segment is also expected to grow in the forecast period of 2017–2025 owing to growing awareness of the benefits of biosimulation, such as bridging the gaps that hinder the drug discovery process, which would enable lowering drug failure rates. The demand for biosimulation in drug discovery would also rise in the forecast period as there would be an increased demand for personalized medicines, which would require lead and target identification and optimization.

For the purpose of this study, the biosimulation market is categorized into three segments:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Biosimulation provides simulation of biological systems, thus rendering it most beneficial in the clinical trial development process and preventing the risks of drug failure. For the purpose of this study, the global biosimulation market is segmented into six regional markets: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America had the largest share of the biosimulation market among the aforementioned regions.

The major factors that drive this predominance in the North American market are the following: an increase in drug development initiations; stringent regulatory policies ensuring patient safety and efficacy standards, thus raising the demand to pre-analyze the success rate of the molecule before entering clinical trials; a rise in the number of strategic collaborations between pharmaceutical industries and research institutes; and in silico developers for simulation-based drug development.

Asia-Pacific is projected to show positive growth in the biosimulation market during the forecast period, 2017–2025. The drivers propelling this market are the increasing presence of CROs, the development of healthcare infrastructure, the penetration of healthcare IT, and an extensive initiation of research and development activities.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Biosimulation Market Portraiture
2.1.1. Global Biosimulation Market, By Software Type, 2016 (US$ Mn)
2.1.2. Global Biosimulation Market, By Application , 2016 (US$ Mn)
2.1.3. Global Biosimulation Market, By Geography, 2016 (Value %)

Chapter 3. Biosimulation Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Biosimulation : Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape, by Key Players, 2016

Chapter 4. Biosimulation Market, by Software Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Biosimulation Market, by Software Type, 2016
4.2. PK/PD Modeling and Simulation Software
4.3. Molecular Modeling and Simulation Software
4.4. PBPK Modeling and Simulation Software
4.5. Toxicity Prediction Software
4.6. Trial Design Software
4.7. Other Software’s.

Chapter 5. Biosimulation Market, by Application , 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Biosimulation Market, by Application, 2016
5.2. Drug Development
5.2.1. Preclinical testing
5.2.2. Clinical trials
5.3. Drug Discovery
5.3.1. Lead Analysis (Identification & Optimization)
5.3.2. Target Analysis (Identification & Optimization)

Chapter 6. Global Biosimulation Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Biosimulation Market Analysis, 2015 – 2025
6.2.1. North America Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.2.3. North America Biosimulation Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Biosimulation Market Analysis, 2015 – 2025
6.3.1. Europe Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.3.3. Europe Biosimulation Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Biosimulation Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Biosimulation Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America Biosimulation Market Analysis, 2015 – 2025
6.5.1. Latin America Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.5.3. Latin America Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Mexico
6.5.3.2. Brazil
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Biosimulation Market Analysis, 2015 – 2025
6.6.1. MEA Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.6.3. MEA Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Medtronic
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Certara USA, Inc.
7.3. Simulation Plus, Inc.
7.4. Dassault Systems SA
7.5. Schrodinger, Inc.
7.6. Advanced Chemistry Development, Inc.
7.7. Chemical Computing Group, Inc.
7.8. Physiomics PLC
7.9. Entelos, Inc.
7.10. Rhenovia Pharma Ltd.
7.11. Genedata AG
7.12. Evidera, Inc.
7.13. In Silico Biosciences Inc.
7.14. Oxford Drug Design
7.15. Insilico Biotechnology AG
7.16. Leadinvent technologies Pvt Ltd.
7.17. Leadscope, Inc.

List of Figures

FIG. 1 Biosimulation : Market Segmentation
FIG. 2 Attractive Investment Proposition, by Geography, 2016
FIG. 3 Market Competition Landscape, by Key Players, 2016
FIG. 4 Global PK/PD Modeling and Simulation Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 5 Global Molecular Modeling and Simulation Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 6 Global PBPK Modeling and Simulation Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 7 Global Toxicity Prediction Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 8 Global Trial Design Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 9 Global Other Software’s Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 10 Global Pre-clinical Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 11 Global Clinical Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 12 Global Lead Analysis Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 13 Global Target Analysis Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 14 U.S. Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 15 Canada Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 16 U.K. Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 17 Germany Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 18 Rest Of Europe Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 21 Rest Of Asia Pacific Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 22 Mexico Biosimulation Market 2015-2025 (US$ Mn)
FIG. 23 Brazil Biosimulation Market 2015-2025 (US$ Mn)
FIG. 24 Rest of Latin America Biosimulation Market 2015-2025 (US$ Mn)
FIG. 25 GCC Biosimulation Market 2015-2025 (US$ Mn)
FIG. 26 Rest of MEA Biosimulation Market 2015-2025 (US$ Mn)

List of Tables

TABLE 1 Global Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Biosimulation Market Share, By Application , 2016 (US$ Mn)
TABLE 3 Global Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 4 Global Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 5 Global Biosimulation Market, By Geography, 2015 – 2025 (US$ Mn)
TABLE 6 North America Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 7 North America Biosimulation Market, By Application, 2015 – 2025 (US$ Mn)
TABLE 8 North America Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 9 North America Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 10 North America Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
TABLE 13 Europe Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 14 Europe Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 15 Europe Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 17 Asia Pacific Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
TABLE 18 Asia Pacific Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 19 Asia Pacific Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 20 Asia Pacific Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 21 Latin America Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 22 Latin America Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
TABLE 23 Latin America Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 24 Latin America Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 25 Latin America Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 26 Middle East And Africa Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 27 Middle East And Africa Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
TABLE 28 Middle East And Africa Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 29 Middle East And Africa Biosimulation Market By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 30 Middle East And Africa Biosimulation Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 31 Certara USA, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Simulation Plus, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Dassault Systems SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Schrodinger, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Advanced Chemistry Development, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Chemical Computing Group, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 37 Physiomics PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 38 Entelos, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 39 Rhenovia Pharma Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 40 Genedata AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 41 Evidera, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 42 In Silico Biosciences Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 43 Oxford Drug Design: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 44 Insilico Biotechnology AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 45 Leadinvent technologies Pvt Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 46 Leadscope, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

Frequently Asked Question

What is the size of Biosimulation Market?

The market for Biosimulation Market is expected to reach USD$ 4.12 Bn in 2025.

What is the Biosimulation Market CAGR?

The Biosimulation Market is expected to see significant CAGR growth over the coming years, at 14.8 %.

What is the Forecast period considered for Biosimulation Market?

The report is forecasted to 2017-2025.

What is the base year considered for Biosimulation Market?

The base year of this report is 2016.

Who are the major players in this market?

Dassault Systems SA, Schrodinger, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group, Inc., Physiomics PLC, Entelos, Inc., Rhenovia Pharma Ltd. are some of the major players in the global market.

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

Pediatric Bladder Treatment Market

Published:
Report ID: 33540

Neurotrophic Keratitis Treatment Market

Published:
Report ID: 33425

Precision Medicine Market

Published:
Report ID: 11123

Eosinophilic Pneumonia Treatment Market

Published:
Report ID: 5486

Myelodysplastic Syndrome Market

Published:
Report ID: 32821

US Retail Pharmacy Market

Published:
Report ID: 32801

Basal Cell Carcinoma (BCC) Treatment Market

Published:
Report ID: 32698

Paroxysmal Nocturnal Hemoglobinuria Market

Published:
Report ID: 8654

Reversible Airway Diseases Treatment Market

Published:
Report ID: 32531

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN